KRAS and colorectal carcinoma: Although the KRAS mutation rates in our PRH cohort were markedly lower than what has been reported in non-Hispanic Blacks, the higher frequency of KRAS mutations in codon 12 could be a contributing factor to the comparable and significantly higher relative risk of CRC death reported for PRH and non-Hispanic Blacks compared to non-Hispanic Whites [2].